Product details
Catalog number BNC743113-100
Price for BNC743113-100
Size / count 1x 100 µL
TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4 Th1 and CD8 Tc1) but not on helper T cells (CD4 Th2 and CD8 Tc2) . In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (TIM3/3113), CF740 conjugate, 0.1mg/mL is BNC743113-100.
TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (TIM3/3113), CF740 conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.
TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (TIM3/3113), CF740 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (TIM3/3113), CF740 conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (TIM3/3113), CF740 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (TIM3/3113), CF740 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0296061270361e1001d5/msds/bnc743113-100.pdf.
TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4 Th1 and CD8 Tc1) but not on helper T cells (CD4 Th2 and CD8 Tc2) . In chronic inflammation, autoimmune disorders, and some cancers, TI
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.
Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.